Q-omics provides the consensus-scored MTRNR2L1 profile across patient tissues and cancer cell-line models. MTRNR2L1 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in ACC. Additionally, MTRNR2L1 RNA expression shows 8,606 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight ACC as cancer lineages where MTRNR2L1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.